Cargando…
Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection
BACKGROUND: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations. CASE DESCRIPTION: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successfu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451510/ https://www.ncbi.nlm.nih.gov/pubmed/36093306 http://dx.doi.org/10.12890/2022_003475 |
Sumario: | BACKGROUND: Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations. CASE DESCRIPTION: We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization. DISCUSSION: Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency. LEARNING POINTS: Haemoptysis is a rare atypical presentation that can reveal COVID-19, highlighting the complexity of its pathogenesis. Atypical manifestations should raise suspicion for COVID-19. In this patient with COVID-19, life-threatening massive haemoptysis was successfully treated with endovascular embolisation. |
---|